Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress-Reference-Cited by-同舟云学术

Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress

Published:2023-04 Issue: Volume:653 Page:53-61
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Wang Zhongli^ORCID,Zhai Jianlong,Zhang Tingting,He Lili,Ma Sai^ORCID,Zuo Qingjuan^ORCID,Zhang Guorui,Wang Yan,Guo Yifang^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference38 articles.

1. Patients with hypertensive nephropathy and chronic kidney disease might not benefit from strict blood pressure control;Vettoretti;Kidney Blood Press. Res.,2018

2. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial;Pimenta;Hypertension,2009

3. Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program;Galletti;J. Hum. Hypertens.,2016

4. Association between Salt Sensitivity and Target Organ Damage in Essential Hypertension..

5. Sodium sensitivity and cardiovascular events in patients with essential hypertension;Morimoto;Lancet,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirtuin 3 in renal diseases and aging: From mechanisms to potential therapies;Pharmacological Research;2024-08

2. Reactive oxygen species in hypertension;Nature Reviews Cardiology;2024-07-24

3. The Role of Mitochondrial Sirtuins (SIRT3, SIRT4 and SIRT5) in Renal Cell Metabolism: Implication for Kidney Diseases;International Journal of Molecular Sciences;2024-06-25

4. SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells;Cellular & Molecular Biology Letters;2024-05-29

5. SGLT-2 inhibitors as novel treatments of multiple organ fibrosis;Heliyon;2024-04